Smart Steps to Growth: Unleashing AI for Assessing Motor Skills in School Children

NCT07083726 | Active Not Recruiting DMC

• 1 other identifier: 202401852B0
• Study Type: observational
• Target: 250
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to develop an AI-based automated motor function assessment system (AIMAS) to improve early identification of developmental coordination disorder (DCD) in school-age children. The main hypothesis for this study is: Integrating AI into motor skill assessments will enhance the reliability, validity, efficiency, and accuracy of evaluating motor performance in children aged 6 to 12.

Conditions

AIMAS; Developmental Coordination Disorder

Keywords

Schoolchildren; Assessment; Artificial Intelligence; Motor; Developmental coordination disorder

Outcome Measures

Primary Outcomes (2)

• Motor Function Assessment Score

  AI-based Motor Function Test (Higher scores indicate better motor performance and lower risk of Developmental Coordination Disorder (DCD).)

  Baseline

• DCD Risk Classification

  AIMAS System Classification (System's ability to identify children at risk of DCD, compared to clinical diagnosis.)

  Baseline

Secondary Outcomes (1)

• The Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2)

  baseline

Study Arms (2)

Typically Developing Children

School-age children aged 6 to 12 years who do not have a diagnosis of developmental coordination disorder (DCD).

Developmental Coordination Disorder children

School-age children aged 6 to 12 years who have a confirmed diagnosis of DCD.

Eligibility Criteria

• Age: 6 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

The study will recruit 250 school-age children, aged 6 to 12, including 170 typically developing children and 80 children with DCD.

You may qualify if:

• Children aged 6 to 12 years.
• For DCD group: formal diagnosis of Developmental Coordination Disorder (DCD).
• For typically developing group: no disabilities or developmental delays.

You may not qualify if:

• Acute illnesses (e.g., pneumonia, upper gastrointestinal hemorrhage).
• Significant developmental delays or disabilities.
• Genetic diseases or disorders.
• Neurological disorders or injuries.

Sponsors & Collaborators

• Chang Gung Memorial Hospital: lead

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

Biospecimen

Retention: SAMPLES WITH DNA

Samples with DNA

MeSH Terms

Conditions

Motor Skills Disorders

Condition Hierarchy (Ancestors)

Neurodevelopmental Disorders; Mental Disorders

Study Officials

• Chia-Ling Chen

  Chang Gung Memorial Hospital

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 16, 2025
• First Posted: July 24, 2025
• Study Start: August 1, 2025
• Primary Completion (Estimated): July 31, 2028
• Study Completion (Estimated): July 31, 2028
• Last Updated: September 5, 2025

Record last verified: 2025-07

Locations

TW (1)